Opinion
Published on 18 May 2022
Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.903679
- 5,089 views
- 22 citations
Type at least 3 characters
1,127 articles
Articles
Mini Review
Published on 18 May 2022
Functions of IFNλs in Anti-Bacterial Immunity at Mucosal Barriers
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.857639
- 3,983 views
- 9 citations
Original Research
Published on 06 May 2022
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.880298
- 17,353 views
- 163 citations
Original Research
Published on 03 May 2022
Selective Targeting of IL-15Rα Is Sufficient to Reduce Inflammation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.886213
- 6,281 views
- 6 citations
Original Research
Published on 02 May 2022
Extracellular Vesicles From TNFα Preconditioned MSCs: Effects on Immunomodulation and Bone Regeneration
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.878194
- 5,709 views
- 37 citations
Opinion
Published on 29 Apr 2022
Optical Control of Adenosine A3 Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.904762
- 1,369 views
- 2 citations
Review
Published on 27 Apr 2022
Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.877243
- 4,141 views
- 5 citations
Original Research
Published on 22 Apr 2022
Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.867167
- 4,696 views
- 5 citations
Original Research
Published on 13 Apr 2022
Bioactive Lipids as Chronic Myeloid Leukemia’s Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.840173
- 4,203 views
- 5 citations
Mini Review
Published on 11 Apr 2022
Extracellular cAMP-Adenosine Pathway Signaling: A Potential Therapeutic Target in Chronic Inflammatory Airway Diseases
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.866097
- 6,607 views
- 16 citations
Original Research
Published on 07 Apr 2022
Skin Interstitial Fluid and Plasma Multiplex Cytokine Analysis Reveals IFN-γ Signatures and Granzyme B as Useful Biomarker for Activity, Severity and Prognosis Assessment in Vitiligo
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.872458
- 5,128 views
- 7 citations
Hypothesis and Theory
Published on 06 Apr 2022
What Is IL-1 for? The Functions of Interleukin-1 Across Evolution
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.872155
- 20,441 views
- 46 citations
Original Research
Published on 05 Apr 2022
IL-27 Modulates the Cytokine Secretion in the T Cell–Osteoclast Crosstalk During HIV Infection
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.818677
- 2,780 views
- 2 citations
Original Research
Published on 01 Apr 2022
IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in Lymphoma
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.856039
- 4,095 views
- 14 citations
Review
Published on 31 Mar 2022
Interleukin-22 in Renal Protection and Its Pathological Role in Kidney Diseases
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.851818
- 6,228 views
- 9 citations
Opinion
Published on 29 Mar 2022
Purinergic Signalling in Group A Streptococcus Pathogenesis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.872053
- 2,185 views
- 2 citations